Means and method for enhancing nucleic acid hybridization

• US 5,030,557 A
• Filed: 11/24/1987
• Issued: 07/09/1991
• Est. Priority Date: 11/24/1987
• Status: Expired due to Term

• Current Assignee: Gen-Probe Incorporated (Hologic Incorporated)
• Original Assignee: ML Technology Ventures LP (Bank of America Corp.)
• Inventors: Milliman, Curt L., Hogan, James J.
• Primary Examiner(s): Wax, Robert A.
• Assistant Examiner(s): Zitomer, Stephanie W.
• Application Number:
  US07/124,975
• Time in Patent Office: 1,323 Days
• Field of Search: 435/6, 435/170, 435/810, 436/501, 536/27, 536/28, 536/26, 935/77, 935/78
• US Class Current: 435/6.16
• CPC Class Codes: C12Q 1/12 Nitrate to nitrite reducing bacteria
• CPC Class Codes: C12Q 1/6832 Enhancement of hybridisation reaction
• CPC Class Codes: C12Q 1/689 for bacteria
• CPC Class Codes: Y10S 435/81 Packaged device or kit

Abstract

The binding of a nucleic acid probe with its complementary sequence in a targeted, single stranded nucleic acid is affected by the secondary and tertiary structure of the target nucleic acid. The rate and extent of hybridization of the probe with the targeted nucleic acid can be increased by the use of "helper" oligonucleotides. Helper oligonucleotides are selected to bind to the target nucleic acid and impose a different secondary and tertiary structure on the target to facilitate the binding of the probe to the target. The resulting hybrid of probe and target nucleic acid also exhibits a higher T_m than the hybrid which results from addition of the probe alone.

Claims

1. A process for enhancing the binding between a nucleotide probe and a complementary nucleotide sequence in a single stranded target nucleic acid comprising adding to the target nucleic acid a helper oligonucleotide which hybridizes with the target nucleic acid in a different region than the probe, the helper oligonucleotide being added in an amount effective to enhance the binding of the probe to the target nucleic acid.

2. A process according to claim 1 wherein the target nucleic acid is selected from DNA, mRNA, rRNA and tRNA.

3. A process according to claim 2 wherein the target nucleic acid is separated from an organism producing it or in which it is found prior to the addition of the helper oligonucleotide and the nucleotide probe.

4. A process according to claim 2 wherein the helper oligonucleotide and the nucleotide probe are introduced to a cell in which the target nucleic acid is located and the hybridization between the target nucleic acid and the helper oligonucleotide and nucleotide probe occurs intracellularly.

5. A process according to any of claims 1, 2, 3 or 4 wherein the probe is a DNA oligonucleotide and the helper oligonucleotide is a DNA oligonucleotide.

6. A process according to claim 5 wherein the probe comprises from about 10 to about 50 nucleotides in length and the helper oligonucleotides comprise from about 10 to about 100 nucleotides in length.

7. A process according to claim 6 wherein the probe and helper oligonucleotides are selected from DNA having a diphosphate ester backbone, an alkyl or arylphosphonate backbone or a phosphorothioate backbone.

8. A process according to claim 7 wherein the probe comprises about 15 to about 40 nucleotides and the helper oligonucleotides comprise from about 20 to about 50 nucleotides.

9. A process according to claim 6 wherein the helper oligonucleotide binds with the target nucleic acid immediately adjacent to the probe.

10. A process according to claim 7 wherein the helper oligonucleotide binds with the target nucleic acid immediately adjacent to the probe.

11. A process according to claim 6 wherein the helper oligonucleotide binds with the target nucleic acid in a region removed from the probe.

12. A process according to claim 7 wherein the helper oligonucleotide binds with the target nucleic acid in a region remote from the probe.

13. A process according to claim 5 wherein the probe is labeled to permit the detection of the probe.

14. A process according to claim 13 wherein the probe is detected after formation of hybrid and separation from the unhybridized probe.

15. A process according to claim 14 wherein the label is a radionucleotide, an enzyme, a fluorometric moiety or a moiety which participates in a reaction which produces chemiluminescence.

16. A process according to claim 15 wherein the label is elected from ¹²⁵ I or an acridinium ester.

17. A process according to claim 5 wherein a mixture of helper oligonucleotides is used.

18. A process according to claim 6 wherein a mixture of helper oligonucleotides is used.

19. A process according to claim 14 wherein a mixture of helper oligonucleotides is used.

20. A process according to claim 15 wherein a mixture of helper oligonucleotides is used.

21. A hybrid nucleic acid comprising a hybrid of a nucleotide probe and a target nucleic acid to which is hybridized a helper oligonucleotide.

22. A hybrid according to claim 21 wherein the duplex is comprised of more than one helper oligonucleotide.

23. A kit for the detection of a target nucleic acid comprising a labeled nucleotide probe complementary to a nucleotide sequence in the target nucleic acid and a helper oligonucleotide.

24. A kit according to claim 23 comprising two or more helper oligonucleotides.

25. A kit according to claim 24 wherein the kit contains two or more probes and two or more helper oligonucleotides.

26. A kit according to claim 25 wherein each probe has a helper oligonucleotide.

27. A kit according to claim 26 wherein one or more probes has two or more helper oligonucleotides.